Sign in

CIK 0001622229

  • Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465308248
Phone
+1 617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,689,493
in 1 filing, $1.7M under 10b5-1 plans

Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Morris Arlene −$1.7M Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2025-12-26 Kearns Evan Chief Legal Officer Sale −65,000 $38.70 $2.5M 109,398
2025-12-17 Kearns Evan Chief Legal Officer Grant or award +40,000 40,000
2025-12-17 Kearns Evan Chief Legal Officer Grant or award +260,000 300,000
2025-12-17 Kearns Evan Chief Legal Officer Shares withheld for taxes −125,602 $39.45 $5.0M 174,398
2025-12-17 Kearns Evan Chief Legal Officer Grant or award · Stock Option (Right to Buy) +55,000 55,000
2025-01-23 Kearns Evan Chief Legal Officer Grant or award · Stock Option (Right to Buy) +230,000 230,000
2024-01-23 Kearns Evan Chief Legal Officer Grant or award · Stock Option (Right to Buy) +255,000 255,000
2023-02-13 Kearns Evan Chief Legal Officer Grant or award · Stock Option (Right to Buy) +140,000 140,000
2022-01-25 Kearns Evan Chief Legal Officer Grant or award · Stock Option (Right to Buy) +202,250 $4.94 $1000K 202,250
2021-05-03 Kearns Evan Chief Legal Officer Grant or award · Stock Option (Right to Buy) +260,000 260,000

Page 1 of 1 · 10 trades